[1]
Kabir, A.L., Islam, K.M.K., Rahman, M., Shah, M.S., Ahmed, M., Sharmin, M., Roy, C.K. and Rahman, F. 2024. Early Molecular Response to Imatinib Mesylate Predicts Long-Term Outcomes in CML Patients in A Postgraduate Research Institute — A single center Study. The Planet. 7, 01 (Feb. 2024), 255–266.